切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - M4 Receptors - Hck - DPP-4

11件产品中的 1-10

页面
每页
清除全部
  1. Talabostat mesylate
    B3941 Talabostat mesylate
     2 Citation
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥11.45 mg/mL
      ≥31 mg/mL
  2. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  3. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  4. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  5. Saxagliptin
    A8650 Saxagliptin
    中文名: 沙格列汀
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥14.85 mg/mL
      ≥8.32 mg/mL
  6. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. Teneligliptin hydrobromide
    A3865 Teneligliptin hydrobromide
    中文名: 氢溴酸替格列汀
    Target: DPP-4
    Summary: DDP4抑制剂
      ≥62.9 mg/mL
      ≥104.8 mg/mL
  9. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Aurora A/B抑制剂
      ≥25.25 mg/mL
      insoluble in H2O
  10. Alogliptin (SYR-322)
    A4038 Alogliptin (SYR-322)
     1 Citation
    中文名: 阿格列汀
    Target: DPP-4
    Summary: DPP-4抑制剂
      ≥14.75 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页